生合生物科技股份有限公司 Approved
最後更新時間 2025/07/18 , 07:14 AM
最後更新時間 2025/07/18 , 07:14 AM
負責人
Yang,Lian-Chuan
統一編號
70402724
成立日期
2000/06/01
資本額
NT$500,000,000
實收資本額
NT$344,748,000
股票代號
1295
電話
07-6955697
地址
No. 66, Beiling 6th Rd., Luzhu Dist., Kaohsiung City, 821, Taiwan
網站
董監事
姓名 職稱 持有股份 代表法人
Yang,Lian-Chuan Chairman 3.75%
Liu,Zhao-Ming Director 0.87%
Yang,San-Lian Director 4.19%
ZHAO CHENG INVESTMENT CO., LTD. Director 15.95%
Jiang,Jiang-Shui Director 2.07%
Chen,Guo-Xiong Independent Director 0.00%
Qu,Shao-Mei Independent Director 0.00%
Cha,Ming-Bang Independent Director 0.00%
Lai,Guan-You Independent Director 0.00%
營業項目
  • Manufacture of Dairy Products(085099)
  • Other Professional, Scientific and Technical Activities Not Elsewhere Classified(760912)
  • Wholesale of Other Food(454911)
  • Management Consultancy Activities(702099)
  • 公司歷程
  • Change Capital to 500,000,000
    2019/07/03
  • Change Capital to 300,000,000
    2017/09/06
  • Change Capital to 230,000,000
    2015/09/29
  • Change Capital to 88,800,000
    2012/12/25
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 233,724 989,483 823,304
    Operating cost 107,997 448,639 404,558
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 125,727 540,844 418,746
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 125,727 540,844 418,746
    Operating expenses 83,310 331,448 275,787
    Other gain (loss), net - - -
    Operating profit (loss) 42,417 209,396 142,959
    Non-operating income and expenses 8,790 27,197 4,108
    Net profit (loss) before tax 51,207 236,593 147,067
    Income tax expense (benefits) 11,838 66,468 33,796
    Net profit (loss) of ongoing business for the current period 39,369 170,125 113,271
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 39,369 170,125 113,271
    Other comprehensive profit (loss), net 7,309 12,441 -6,504
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 46,678 182,566 106,767
    Net profit (loss) attributable to owners of parent company 39,369 170,125 113,271
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 46,678 182,566 106,767
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 1 5 3
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 21,184 261,536 213,932
    Net cash inflows (outflows) from investing activities -131,904 -313,212 -137,167
    Net cash inflow (outflow) from financing activities 45,849 166,033 49,164
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 8,592 8,292 -5,474
    Increase (decrease) in cash and cash equivalents in the current period -56,279 122,649 120,455
    Beginning balance of cash and cash equivalents 469,387 346,738 226,283
    Ending balance of cash and cash equivalents 413,108 469,387 346,738
    項目 2025 2024 2023
    Current asset 730,347 765,733 618,644
    Non-current asset 1,783,411 1,578,771 1,267,596
    Total asset 2,513,758 2,344,504 1,886,240
    Current liability 582,107 411,213 199,281
    Non-current liability 911,810 853,866 743,990
    Total liability 1,493,917 1,265,079 943,271
    share capital 313,548 313,548 307,400
    Equity - secruity token - - -
    capital reserve 254,139 250,659 256,807
    retained earning 443,105 513,478 389,463
    Other equity 9,049 1,740 -10,701
    Treasury stock - - -
    Total equity attributable to owners of parent company 1,019,841 1,079,425 942,969
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 1,019,841 1,079,425 942,969
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 32 34 30
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • GABABIOTICS設計字
  • SYNTEK
  • ABKEFIR
  • SYNPACK
  • SYNPET
  • TWK10
  • SynForU
  • 芯來旺
  • SYNLAC
  • 芯發旺
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Payment order
    2022
  • Return deposit
    2013
  • Invalidating Judgment
    2016
  • Fulfill agreement, etc.
    2012
  • Petition filed for public summons
    2016
  • Confirmation of the existence of debt
    2023, 2024
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。